Carbamazepine Treatment of Cocaine Dependence - 1
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders; Substance-Related Disorders
Intervention: Carbamazepine (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Kathleen Brady, Ph.D., Principal Investigator, Affiliation: Medical University of South Carolina
Summary
The purpose of this study is to compare the efficacy of carbamazepine in treatment of
cocaine-dependence in patients with affective disorders.
Clinical Details
Official title: Carbamazepine Treatment of Cocaine Dependence
Study design: Treatment
Primary outcome: Severity addictionAmount of drug use Affective stability Medication compliance
Eligibility
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
Medical University of South Carolina, Charleston, South Carolina 29425 742, United States
Additional Information
Related publications: (1) Brady KT et. al. Features of cocaine dependence with concurrent alcohol abuse. Drug and Alcohol Depend. 1995, 39(1):69-71. (2) Brady KT et. al. Personality disorder and assault history in substance-dependent individuals. Am J on Addictions. 1995, 4(4):306-312. (3) Dansky et. al. Use of self-report measures of crime-related posttraumatic stress disorder with substance use disordered patients. Journal of Substance Abuse Treatment. (in press). (4) Sonne an
Presentation at CPDD meeting, 1996.
Starting date: October 1992
Last updated: November 3, 2005
|
